SynthesisFrontiers in oncology2021

Efficacy and Safety of Ibrutinib in Central Nervous System Lymphoma: A PRISMA-Compliant Single-Arm Meta-Analysis.

Liwei Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.